ILRUN: A Protein with Potential as A Drug Target Or Biomarker

Target Name: ILRUN

NCBI ID: G64771

ILRUN

ILRUN: A Protein with Potential as A Drug Target Or Biomarker

ILRUN (Protein ILRUN (isoform a)) is a protein that is expressed in various tissues throughout the body, including the brain, heart, lungs, and kidneys. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In recent years, researchers have been interested in studying ILRUN as a potential drug target or biomarker, and a number of studies have investigated its potential role in these areas.

One of the key features of ILRUN is its ability to interact with a variety of different molecules, including cytokines, chemokines, and other proteins. This makes it a potentially promising target for drugs that work by modulating these interactions. For example, some researchers have been interested in investigating the potential of small molecules that can interact with ILRUN and inhibit its activity. This could be useful for treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Another promising aspect of ILRUN is its role in regulating the immune response. ILRUN has been shown to play a key role in the regulation of T cell development and function, as well as in the regulation of inflammation. This makes it a potentially promising target for drugs that are designed to enhance or inhibit the immune response.

In addition to its potential as a drug target, ILRUN has also been investigated as a potential biomarker. The ability of ILRUN to interact with a variety of different molecules makes it a potentially promising marker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Overall, ILRUN is a protein that has the potential to be a valuable drug target or biomarker. While more research is needed to fully understand its role and potential, its properties and interactions make it an intriguing molecule for further study.

Protein Name: Inflammation And Lipid Regulator With UBA-like And NBR1-like Domains

Functions: Negative regulator of innate antiviral response. Blocks IRF3-dependent cytokine production such as IFNA, IFNB and TNF (PubMed:29802199). Interacts with IRF3 and inhibits IRF3 recruitment to type I IFN promoter sequences while also reducing nuclear levels of the coactivators EP300 and CREBBP (PubMed:29802199)

The "ILRUN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ILRUN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets